Which treatment is used for systemic mycosis?

Systemic mycoses are serious fungal infections that can affect various organs and systems within the body. The treatment for these infections typically involves antifungal medications that are effective in targeting the underlying fungal pathogens.

In this context, the chosen treatment option which includes Amphotericin B, itraconazole, fluconazole, and echinocandins represents a broad spectrum approach for addressing systemic fungal infections. Amphotericin B is a polyene antifungal that binds to ergosterol in fungal cell membranes, creating pores that disrupt cellular integrity, making it effective against a wide range of fungi. Itraconazole and fluconazole are azole antifungals that inhibit the synthesis of ergosterol, another critical component of fungal cell membranes. Echinocandins, such as caspofungin, interfere with the synthesis of beta-glucan in the fungal cell wall, further providing an effective mechanism against certain types of fungi, particularly Candida and Aspergillus species.

The other treatments listed do not target systemic mycoses. For instance, amoxicillin and clavulanate are primarily used for bacterial infections. Vancomycin and gentamicin are antibiotics that are effective against specific bacteria but not fungi. Ciprofloxacin and